Bill Ackman’s Pershing Square hedge fund made an inauspicious appearance on an HSBC weekly hedge fund list in a ratings and performance reporting issue out today. Pershing Square cracked the bottom 20 worst performing list – and answers or questions that were or were not asked during Valeant Pharma due diligence might be at fault. Ackman down in performance as SIRF and Citron administer a one-two puch Pershing Square has never finished a year at the bottom of the HSBC performance ranking. For the hedge fund activist that in 2014 finished 8th on the list of best yearly performers, then…
Pershing Square Cracks HSBC's Bottom 20 Ranking: Thanks Valeant
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.